Global Autoimmune Treatment Market Analysis & Trends - Industry Forecast to 2025

  • ID: 4332987
  • Report
  • Region: Global
  • Accuray Research LLP
1 of 4
The Global Autoimmune Treatment Market is poised to grow at a CAGR of around XX% over the next decade to reach approximately $XX million by 2025.

FEATURED COMPANIES

  • Abbott laboratories
  • Bristol-myers squibb co.
  • Forest laboratories, inc.
  • Glaxo smithkline plc
  • Novartis
  • Sanofi-aventis
  • MORE
The Global Autoimmune Treatment Market is poised to grow at a CAGR of around XX% over the next decade to reach approximately $XX million by 2025. Some of the prominent trends that the market is witnessing include increasing public awareness expands the market and emergence of new drugs and therapies to fuel the market

Based on Service the market is categorized into therapy and monitoring, drug development, consultation and diagnosis and other services.

Depending on the Product the market is segmented by diagnostic equipment, therapeutic and monitoring equipment, drugs and other products. Drugs segment is further sub segmented into
calicipotriene, copaxone, methotrexate, aminosalicylates/5-Asa/mesalazine, glucocorticoids, comparison of four MS drugs, anthralin, non-steroidal anti-inflammatory drugs (NSAID), rebif, corticosteriods (Steriods), hydroxychloroquine (HCQ), betaseron, avonex and other drugs.

By Application, market is segregated by Localized Autoimmune Diseases and Systemic Autoimmune Diseases. Localized Autoimmune Diseases segment is further sub segmented into drug approvals, inflammatory bowel diseases (IBD), thyroid diseases, multiple sclerosis (MS), type I diabetes and other localized autoimmune diseases. Systemic Autoimmune Diseases segment is further sub segmented into lupus, psoriasis, rheumatoid arthritis and other systemic autoimmune diseases.

Based on Technology the market is categorized into phototherapy, hematopoietic stem cell transplantation, helminthic therapy, DMARD and biologic DMARD therapy, topical therapy, fecal bacteriotherapy, bridge therapy and recombinant technology

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2014, 2015 revenue estimations are presented for 2016 and forecasts from 2017 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

This report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:

North America
  • US
  • Canada
  • Mexico
Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • New Zealand
  • Rest of Asia Pacific
Middle East
  • Saudi Arabia
  • UAE
  • Rest of Middle East
Latin America
  • Argentina
  • Brazil
  • Rest of Latin America
Rest of the World
  • Africa
  • Caribbean
Report Highlights:
  • The report provides a detailed analysis on current and future market trends to identify the investment opportunities
  • Market forecasts till 2025, using estimated market values as the base numbers
  • Key market trends across the business segments, Regions and Countries
  • Key developments and strategies observed in the market
  • Market Dynamics such as Drivers, Restraints, Opportunities and other trends
  • In-depth company profiles of key players and upcoming prominent players
  • Growth prospects among the emerging nations through 2025
  • Market opportunities and recommendations for new investments
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott laboratories
  • Bristol-myers squibb co.
  • Forest laboratories, inc.
  • Glaxo smithkline plc
  • Novartis
  • Sanofi-aventis
  • MORE
1 Market Outline
1.1 Research Methodology
1.1.1 Research Approach & Sources
1.2 Market Trends
1.3 Regulatory Factors
1.4 Product Analysis
1.5 Technology Analysis
1.5 Application Analysis
1.5 Strategic Benchmarking
1.6 Opportunity Analysis

2 Executive Summary

3 Market Overview
3.1 Current Trends
3.1.1 Increasing public Awareness expands the market
3.1.2 Emergence of New Drugs and Therapies to fuel the market
3.1.3 Recent technological developments in Autoimmune Treatment
3.1.4 Growth opportunities/investment opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
3.4.1 Bargaining power of suppliers
3.4.2 Bargaining power of buyers
3.4.3 Threat of substitutes
3.4.4 Threat of new entrants
3.4.5 Competitive rivalry

4 Autoimmune Treatment Market, By Service
4.1 Therapy and Monitoring
4.1.1 Therapy and Monitoring
4.2 Drug Development
4.2.1 Drug Development
4.3 Consultation and Diagnosis
4.3.1 Consultation and Diagnosis
4.4 Other Services
4.4.1 Other Services

5 Autoimmune Treatment Market, By Product
5.1 Diagnostic Equipment
5.1.1 Diagnostic Equipment Market Forecast to 2025 (US$ MN)
5.2 Therapeutic and Monitoring Equipment
5.2.1 Therapeutic and Monitoring Equipment Market Forecast to 2025 (US$ MN)
5.3 Drugs
5.3.1 Drugs Market Forecast to 2025 (US$ MN)
5.3.1.1 Calicipotriene
5.3.1.1.1 Calicipotriene Market Forecast to 2025 (US$ MN)
5.3.1.2 Copaxone
5.3.1.2.1 Copaxone Market Forecast to 2025 (US$ MN)
5.3.1.3 Methotrexate
5.3.1.3.1 Methotrexate Market Forecast to 2025 (US$ MN)
5.3.1.4 Aminosalicylates/5-Asa/Mesalazine
5.3.1.4.1 Aminosalicylates/5-Asa/Mesalazine Market Forecast to 2025 (US$ MN)
5.3.1.5 Glucocorticoids
5.3.1.5.1 Glucocorticoids Market Forecast to 2025 (US$ MN)
5.3.1.6 Comparison of Four MS Drugs
5.3.1.6.1 Comparison of Four MS Drugs Market Forecast to 2025 (US$ MN)
5.3.1.7 Anthralin
5.3.1.7.1 Anthralin Market Forecast to 2025 (US$ MN)
5.3.1.8 Non-steroidal anti-inflammatory drugs (NSAID)
5.3.1.8.1 Non-steroidal anti-inflammatory drugs (NSAID) Market Forecast to 2025 (US$ MN)
5.3.1.9 Rebif
5.3.1.9.1 Rebif Market Forecast to 2025 (US$ MN)
5.3.1.10 Corticosteriods (Steriods)
5.3.1.10.1 Corticosteriods (Steriods) Market Forecast to 2025 (US$ MN)
5.3.1.11 Hydroxychloroquine (HCQ)
5.3.1.11.1 Hydroxychloroquine (HCQ) Market Forecast to 2025 (US$ MN)
5.3.1.12 Betaseron
5.3.1.12.1 Betaseron Market Forecast to 2025 (US$ MN)
5.3.1.13 Avonex
5.3.1.13.1 Avonex Market Forecast to 2025 (US$ MN)
5.3.1.14 Other Drugs
5.3.1.14.1 Other Drugs Market Forecast to 2025 (US$ MN)
5.4 Other Products
5.4.1 Other Products Market Forecast to 2025 (US$ MN)

6 Autoimmune Treatment Market, By Application
6.1 Localized Autoimmune Diseases
6.1.1 Localized Autoimmune Diseases Market Forecast to 2025 (US$ MN)
6.1.1.1 Drug Approvals
6.1.1.1.1 Drug Approvals Market Forecast to 2025 (US$ MN)
6.1.1.2 Inflammatory Bowel Diseases (IBD)
6.1.1.2.1 Inflammatory Bowel Diseases (IBD) Market Forecast to 2025 (US$ MN)
6.1.1.3 Thyroid Diseases
6.1.1.3.1 Thyroid Diseases Market Forecast to 2025 (US$ MN)
6.1.1.4 Multiple sclerosis (MS)
6.1.1.4.1 Multiple sclerosis (MS) Market Forecast to 2025 (US$ MN)
6.1.1.5 Type I diabetes
6.1.1.5.1 Type I diabetes Market Forecast to 2025 (US$ MN)
6.1.1.6 Other Localized Autoimmune Diseases
6.1.1.6.1 Other Localized Autoimmune Diseases Market Forecast to 2025 (US$ MN)
6.2 Systemic Autoimmune Diseases
6.2.1 Systemic Autoimmune Diseases Market Forecast to 2025 (US$ MN)
6.2.1.1 Lupus
6.2.1.1.1 Lupus Market Forecast to 2025 (US$ MN)
6.2.1.2 Psoriasis
6.2.1.2.1 Psoriasis Market Forecast to 2025 (US$ MN)
6.2.1.3 Rheumatoid Arthritis
6.2.1.3.1 Rheumatoid Arthritis Market Forecast to 2025 (US$ MN)
6.2.1.4 Other Systemic Autoimmune Diseases
6.2.1.4.1 Other Systemic Autoimmune Diseases Market Forecast to 2025 (US$ MN)

7 Autoimmune Treatment Market, By Technology
7.1 Phototherapy
7.1.1 Phototherapy Market Forecast to 2025 (US$ MN)
7.2 Hematopoietic stem cell transplantation
7.2.1 Hematopoietic stem cell transplantation Market Forecast to 2025 (US$ MN)
7.3 Helminthic therapy
7.3.1 Helminthic therapy Market Forecast to 2025 (US$ MN)
7.4 DMARD and biologic DMARD therapy
7.4.1 DMARD and biologic DMARD therapy Market Forecast to 2025 (US$ MN)
7.5 Topical therapy
7.5.1 Topical therapy Market Forecast to 2025 (US$ MN)
7.6 Fecal bacteriotherapy
7.6.1 Fecal bacteriotherapy Market Forecast to 2025 (US$ MN)
7.7 Bridge therapy
7.7.1 Bridge therapy Market Forecast to 2025 (US$ MN)
7.8 Recombinant technology
7.8.1 Recombinant technology Market Forecast to 2025 (US$ MN)

8 Autoimmune Treatment Market, By Geography
8.1 North America
8.1.1 North America Market Forecast by Countries to 2025 (US$ MN)
8.1.1.1 US
8.1.1.2 Canada
8.1.1.3 Mexico
8.2 Europe
8.2.1 Europe Market Forecast by Countries to 2025 (US$ MN)
8.2.1.1 Germany
8.2.1.2 U.K
8.2.1.3 Italy
8.2.1.4 France
8.2.1.5 Spain
8.2.1.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Asia Pacific Market Forecast by Countries to 2025 (US$ MN)
8.3.1.1 China
8.3.1.2 Japan
8.3.1.3 India
8.3.1.4 Australia
8.3.1.5 New Zealand
8.3.1.6 Rest of Asia Pacific
8.4 Middle East
8.4.1 Middle East Market Forecast by Countries to 2025 (US$ MN)
8.4.1.1 Saudi Arabia
8.4.1.2 UAE
8.4.1.3 Rest of Middle East
8.5 Latin America
8.5.1 Latin America Market Forecast by Countries to 2025 (US$ MN)
8.5.1.1 Argentina
8.5.1.2 Brazil
8.5.1.3 Rest of Latin America
8.6 Rest of the World (RoW)
8.6.1 RoW Market Forecast by Countries to 2025 (US$ MN)
8.6.1.1 Africa
8.6.1.2 Caribbean

9 Key Player Activities
9.1 Acquisitions & Mergers
9.2 Agreements, Partnerships, Collaborations and Joint Ventures
9.3 Product Launch & Expansions
9.4 Other Activities

10 Leading Companies
10.1 Abbott laboratories
10.2 Autoimmune inc
10.3 Bayer-schering pharmaceuticals
10.4 Bristol-myers squibb co.
10.5 Eli lilly & co.
10.6 Forest laboratories, inc.
10.7 Genentech, inc.
10.8 Glaxo smithkline plc
10.9 Johnson & johnson
10.10 Mitsubishi tanabe pharma corp
10.11 Novartis
10.12 Pfizer
10.13 Sanofi-aventis
10.14 Teva

List of Tables
Table 1 Global Autoimmune Treatment Market By Region, Market Forecast (2014-2025) (US$ MN)
Table 2 Global Autoimmune Treatment Market By Service, Market Forecast (2014-2025) (US$ MN)
Table 3 Global Autoimmune Treatment Market By Therapy and Monitoring, Market Forecast (2014-2025) (US$ MN)
Table 4 Global Autoimmune Treatment Market By Drug Development, Market Forecast (2014-2025) (US$ MN)
Table 5 Global Autoimmune Treatment Market By Consultation and Diagnosis, Market Forecast (2014-2025) (US$ MN)
Table 6 Global Autoimmune Treatment Market By Other Services, Market Forecast (2014-2025) (US$ MN)
Table 7 Global Autoimmune Treatment Market By Product, Market Forecast (2014-2025) (US$ MN)
Table 8 Global Autoimmune Treatment Market By Diagnostic Equipment, Market Forecast (2014-2025) (US$ MN)
Table 9 Global Autoimmune Treatment Market By Therapeutic and Monitoring Equipment, Market Forecast (2014-2025) (US$ MN)
Table 10 Global Autoimmune Treatment Market By Drugs, Market Forecast (2014-2025) (US$ MN)
Table 11 Global Autoimmune Treatment Market By Calicipotriene, Market Forecast (2014-2025) (US$ MN)
Table 12 Global Autoimmune Treatment Market By Copaxone, Market Forecast (2014-2025) (US$ MN)
Table 13 Global Autoimmune Treatment Market By Methotrexate, Market Forecast (2014-2025) (US$ MN)
Table 14 Global Autoimmune Treatment Market By Aminosalicylates/5-Asa/Mesalazine, Market Forecast (2014-2025) (US$ MN)
Table 15 Global Autoimmune Treatment Market By Glucocorticoids, Market Forecast (2014-2025) (US$ MN)
Table 16 Global Autoimmune Treatment Market By Comparison of Four MS Drugs, Market Forecast (2014-2025) (US$ MN)
Table 17 Global Autoimmune Treatment Market By Anthralin, Market Forecast (2014-2025) (US$ MN)
Table 18 Global Autoimmune Treatment Market By Non-steroidal anti-inflammatory drugs (NSAID), Market Forecast (2014-2025) (US$ MN)
Table 19 Global Autoimmune Treatment Market By Rebif, Market Forecast (2014-2025) (US$ MN)
Table 20 Global Autoimmune Treatment Market By Corticosteriods (Steriods), Market Forecast (2014-2025) (US$ MN)
Table 21 Global Autoimmune Treatment Market By Hydroxychloroquine (HCQ), Market Forecast (2014-2025) (US$ MN)
Table 22 Global Autoimmune Treatment Market By Betaseron, Market Forecast (2014-2025) (US$ MN)
Table 23 Global Autoimmune Treatment Market By Avonex, Market Forecast (2014-2025) (US$ MN)
Table 24 Global Autoimmune Treatment Market By Other Drugs, Market Forecast (2014-2025) (US$ MN)
Table 25 Global Autoimmune Treatment Market By Other Products, Market Forecast (2014-2025) (US$ MN)
Table 26 Global Autoimmune Treatment Market By Application, Market Forecast (2014-2025) (US$ MN)
Table 27 Global Autoimmune Treatment Market By Localized Autoimmune Diseases, Market Forecast (2014-2025) (US$ MN)
Table 28 Global Autoimmune Treatment Market By Drug Approvals, Market Forecast (2014-2025) (US$ MN)
Table 29 Global Autoimmune Treatment Market By Inflammatory Bowel Diseases (IBD), Market Forecast (2014-2025) (US$ MN)
Table 30 Global Autoimmune Treatment Market By Thyroid Diseases, Market Forecast (2014-2025) (US$ MN)
Table 31 Global Autoimmune Treatment Market By Multiple sclerosis (MS), Market Forecast (2014-2025) (US$ MN)
Table 32 Global Autoimmune Treatment Market By Type I diabetes, Market Forecast (2014-2025) (US$ MN)
Table 33 Global Autoimmune Treatment Market By Other Localized Autoimmune Diseases, Market Forecast (2014-2025) (US$ MN)
Table 34 Global Autoimmune Treatment Market By Systemic Autoimmune Diseases, Market Forecast (2014-2025) (US$ MN)
Table 35 Global Autoimmune Treatment Market By Lupus, Market Forecast (2014-2025) (US$ MN)
Table 36 Global Autoimmune Treatment Market By Psoriasis, Market Forecast (2014-2025) (US$ MN)
Table 37 Global Autoimmune Treatment Market By Rheumatoid Arthritis, Market Forecast (2014-2025) (US$ MN)
Table 38 Global Autoimmune Treatment Market By Other Systemic Autoimmune Diseases, Market Forecast (2014-2025) (US$ MN)
Table 39 Global Autoimmune Treatment Market By Technology, Market Forecast (2014-2025) (US$ MN)
Table 40 Global Autoimmune Treatment Market By Phototherapy, Market Forecast (2014-2025) (US$ MN)
Table 41 Global Autoimmune Treatment Market By Hematopoietic stem cell transplantation, Market Forecast (2014-2025) (US$ MN)
Table 42 Global Autoimmune Treatment Market By Helminthic therapy, Market Forecast (2014-2025) (US$ MN)
Table 43 Global Autoimmune Treatment Market By DMARD and biologic DMARD therapy, Market Forecast (2014-2025) (US$ MN)
Table 44 Global Autoimmune Treatment Market By Topical therapy, Market Forecast (2014-2025) (US$ MN)
Table 45 Global Autoimmune Treatment Market By Fecal bacteriotherapy, Market Forecast (2014-2025) (US$ MN)
Table 46 Global Autoimmune Treatment Market By Bridge therapy, Market Forecast (2014-2025) (US$ MN)
Table 47 Global Autoimmune Treatment Market By Recombinant technology, Market Forecast (2014-2025) (US$ MN)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott laboratories
  • Autoimmune inc
  • Bayer-schering pharmaceuticals
  • Bristol-myers squibb co.
  • Eli lilly & co.
  • Forest laboratories, inc.
  • Genentech, inc.
  • Glaxo smithkline plc
  • Johnson & johnson
  • Mitsubishi tanabe pharma corp
  • Novartis
  • Pfizer
  • Sanofi-aventis
  • Teva
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll